Literature DB >> 29599381

Secondary mania following cancer chemotherapy with capecitabine.

Harshit Garg1, Sathya Prakash1, Koushik Sinha Deb1, Rakesh Kumar Chadda1.   

Abstract

Mania-like states occurring due to neurological, metabolic or toxic conditions, without a primary mood disorder have been reported in scientific literature as secondary mania. A major clinical problem in such situations often stems from the difficulty to understand if the mood disturbance is indeed secondary to an organic cause or a coincidental primary mood disorder. Chemotherapy regimens have been associated with multiple psychiatric complications, including psychosis, mania and anxiety. Capecitabine is implicated to be associated with encephalopathy whose clinical presentation often mimics that of psychosis. However, presentations with mania have not been reported until with the capecitabine and oxaliplatin combination chemotherapy regimen. In this report, we describe a case of secondary mania in a patient suffering from carcinoma colon on treatment with chemotherapy regimen of capecitabine and oxaliplatin. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  malignant disease and immunosuppression; mood disorders (including depression)

Mesh:

Substances:

Year:  2018        PMID: 29599381      PMCID: PMC5878383          DOI: 10.1136/bcr-2017-220995

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  ACUTE CEREBELLAR SYNDROME SECONDARY TO 5-FLUOROURACIL THERAPY.

Authors:  J L RIEHL; W J BROWN
Journal:  Neurology       Date:  1964-10       Impact factor: 9.910

2.  Toxic encephalopathy induced by capecitabine.

Authors:  B Niemann; C Rochlitz; R Herrmann; M Pless
Journal:  Oncology       Date:  2004       Impact factor: 2.935

3.  A case of manic episode during treatment with 5-fluorouracil, epirubicin and cyclophosphamide for breast cancer.

Authors:  Isabella Pacchiarotti; Lorenzo Mazzarini; Patrizia Pellegrini; Viola Venturelli; Gabriele Sani; José Sánchez-Moreno; Iginia Mancinelli; Roberto Tatarelli; Giorgio D Kotzalidis; Paolo Girardi
Journal:  Gen Hosp Psychiatry       Date:  2007 Sep-Oct       Impact factor: 3.238

Review 4.  Subacute reversible toxic encephalopathy related to treatment with capecitabine: a case report with literature review and discussion of pathophysiology.

Authors:  E Lyros; S Walter; I Keller; P Papanagiotou; K Fassbender
Journal:  Neurotoxicology       Date:  2014-03-11       Impact factor: 4.294

5.  Chemotherapy-induced acute psychosis in a patient with malignant germ cell tumour.

Authors:  Umamon Puangthong; Krit Pongpirul
Journal:  BMJ Case Rep       Date:  2015-04-09

6.  Secondary mania: manic syndromes associated with antecedent physical illness or drugs.

Authors:  C Krauthammer; G L Klerman
Journal:  Arch Gen Psychiatry       Date:  1978-11

7.  A case of 5-fluorouracil-induced acute psychosis.

Authors:  Ahmad Fora; Eyad Alabsi; Marwan Fakih
Journal:  Clin Colorectal Cancer       Date:  2009-07       Impact factor: 4.481

Review 8.  Secondary mania: diagnosis and treatment.

Authors:  D L Evans; M J Byerly; R A Greer
Journal:  J Clin Psychiatry       Date:  1995       Impact factor: 4.384

9.  Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy.

Authors:  Luiz Carlos Porcello Marrone; Bianca Fontana Marrone; Tharick Ali Pascoal; Lucas Porcello Schilling; Ricardo Bernardi Soder; Sheila Schuch Ferreira; Giovani Gadonski; Jaderson Costa da Costa
Journal:  Case Rep Oncol Med       Date:  2013-02-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.